VICENTINI, Caterina
 Distribuzione geografica
Continente #
EU - Europa 2.641
NA - Nord America 2.422
AS - Asia 1.794
SA - Sud America 214
AF - Africa 38
OC - Oceania 8
Totale 7.117
Nazione #
US - Stati Uniti d'America 2.373
RU - Federazione Russa 1.035
CN - Cina 644
SG - Singapore 603
GB - Regno Unito 495
IT - Italia 298
DE - Germania 182
VN - Vietnam 182
BR - Brasile 164
HK - Hong Kong 147
SE - Svezia 140
IE - Irlanda 136
FR - Francia 118
FI - Finlandia 88
KR - Corea 54
CA - Canada 27
IN - India 24
ES - Italia 23
UA - Ucraina 23
JP - Giappone 22
NL - Olanda 21
BD - Bangladesh 17
BE - Belgio 17
TR - Turchia 17
AT - Austria 16
EC - Ecuador 15
PL - Polonia 15
AR - Argentina 13
ID - Indonesia 13
MX - Messico 12
IQ - Iraq 11
MA - Marocco 9
AU - Australia 8
NG - Nigeria 8
UZ - Uzbekistan 8
CH - Svizzera 6
CL - Cile 5
CO - Colombia 5
IR - Iran 5
LT - Lituania 5
VE - Venezuela 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
ET - Etiopia 4
JO - Giordania 4
KG - Kirghizistan 4
MY - Malesia 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
NP - Nepal 3
RS - Serbia 3
TG - Togo 3
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BJ - Benin 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.117
Città #
Southend 440
Moscow 357
Singapore 331
Chandler 319
Ashburn 302
San Jose 225
Dallas 176
Verona 167
Hong Kong 143
Beijing 142
Dublin 127
Woodbridge 112
Ann Arbor 89
New York 81
Jacksonville 79
Munich 62
Houston 57
Ho Chi Minh City 53
The Dalles 53
Los Angeles 49
Shenyang 47
Lawrence 40
Princeton 40
Jinan 38
Hanoi 37
Wilmington 34
Dearborn 32
Helsinki 30
Nanjing 25
Tianjin 25
Hebei 24
Redmond 23
Council Bluffs 22
Tokyo 22
Turku 22
São Paulo 21
Changsha 20
Milan 20
Buffalo 19
Columbus 18
Nanchang 18
Ningbo 18
Redondo Beach 18
Zhengzhou 18
Brussels 17
Frankfurt am Main 15
Guangzhou 15
Orem 15
Santa Clara 15
Denver 14
Hangzhou 14
Sindelfingen 13
Haikou 12
London 12
Taiyuan 12
Warsaw 12
Vienna 11
Amsterdam 10
Brooklyn 10
Madrid 10
Seoul 10
Bologna 9
Jiaxing 9
Paris 9
Poplar 9
Rome 9
Seattle 9
Stockholm 9
Abuja 8
Ankara 8
Biên Hòa 8
Chennai 8
Da Nang 8
Montreal 8
San Francisco 8
Atlanta 7
Dong Ket 7
Jakarta 7
Norwalk 7
Taizhou 7
Tashkent 7
Barnet 6
Chicago 6
Kent 6
Mexico City 6
Redwood City 6
Toronto 6
Washington 6
Baghdad 5
Falkenstein 5
Fuzhou 5
Guayaquil 5
Haiphong 5
Hải Dương 5
Johannesburg 5
New Delhi 5
Nuremberg 5
Piscataway 5
Zurich 5
Addis Ababa 4
Totale 4.474
Nome #
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 286
Whole-genome landscape of pancreatic neuroendocrine tumours 280
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 219
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 214
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 214
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 187
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 184
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Comparative Lesions Analysis Through a Targeted Sequencing Approach 182
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 181
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 179
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 178
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 177
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 177
Fhit down-regulation is an early event in pancreatic carcinogenesis 174
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 172
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 172
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 171
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 166
Loss of FGFR4 promotes the malignant phenotype of PDAC 164
Exosomal miRNA signatures of pancreatic lesions 160
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 153
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 149
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 149
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Long-term organoid culture of a small intestinal neuroendocrine tumor 145
A differentially expressed set of micrornas in cerebro-spinal fluid (CSF) can diagnose CNS malignancies 138
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 131
Current role of non-coding RNAs in the clinical setting 130
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 128
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 124
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer 122
Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth 120
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 120
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 116
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 114
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 107
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 94
miR-15b/16-2 deletion promotes B-cell malignancies 89
MCL1 as putative target in pancreatoblastoma 89
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 68
Totale 7.205
Categoria #
all - tutte 23.776
article - articoli 22.112
book - libri 0
conference - conferenze 1.664
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 11 32 22
2021/2022424 31 136 8 38 10 7 5 28 28 7 36 90
2022/2023849 44 117 70 138 83 196 15 45 101 11 10 19
2023/2024406 18 25 39 29 57 88 19 31 5 27 52 16
2024/2025977 52 45 45 160 39 43 50 33 140 49 106 215
2025/20263.074 212 148 205 559 873 187 284 166 276 164 0 0
Totale 7.205